(1 - 19 from 24
)
EDAP TMS Reports Third Quarter Results | MarketScreener
www.marketscreener.com
EDAP TMS Reports Third Quarter Results EDAP's HIFU patient treatment revenues grew 29% compared to third quarter EDAP received FDA...
FDA panel votes against ablation ultrasound treatment for prostate...
www.healio.com
FDA panel votes against ablation ultrasound treatment for ... localized prostate cancer and we appreciate the dialog during today's meeting,” Marc Oczachowski, ...
EDAP Reports First Quarter Results
www.globenewswire.com
1Q and Recent Operational Highlights Direct De Novo petition for Ablatherm HIFU submitted to the FDA in April 2015;
Treatment-driven...
EDAP Submits U.S. FDA Pre-Market Approval Application for...
www.fusfoundation.org
Accelerating the development and adoption of focused ultrasound to improve the lives of millions of people with serious medical disorders.
sorted by relevance / date